What Major Growth Indicators And Market Expansion Forecasts Define The Glucose Biosensors Market Through 2030?
The glucose biosensors market size has grown rapidly in recent years. It will grow from $16.72 billion in 2025 to $18.83 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increasing prevalence of diabetes, rising demand for home-based monitoring solutions, improvements in biosensor sensitivity, expansion of point-of-care diagnostics, growing patient awareness of glucose management.
The glucose biosensors market size is expected to see rapid growth in the next few years. It will grow to $30.88 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing adoption of digital diabetes management tools, rising demand for non-invasive monitoring, expansion of personalized healthcare solutions, growing investments in biosensor R&D, increasing use of AI-driven glucose analytics. Major trends in the forecast period include increasing adoption of continuous glucose monitoring systems, rising demand for wearable glucose biosensors, growing integration of mobile health platforms, expansion of non-invasive glucose monitoring technologies, enhanced focus on real-time data accuracy.
Claim Your Free Report Sample Today:
Which Drivers Are Playing A Pivotal Role In Shaping The Glucose Biosensors Market’s Growth Outlook?
The rising prevalence of diabetes is expected to propel the growth of the glucose biosensors market going forward. Diabetes is an incurable disease that arises when the pancreas fails to create enough insulin or when the body fails to adequately utilize the insulin that is produced. Diabetes patients utilize glucose biosensors to monitor their blood glucose levels which enables them to monitor their blood glucose levels regularly at their convenience and helps to adjust their medication for better diabetes management. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the glucose biosensors market.
How Is The Glucose Biosensors Market Broken Down Based On Its Critical Segment Classifications?
The glucose biosensors market covered in this report is segmented –
1) By Product Type: Continuous Glucose Monitoring, Self-Monitoring Blood Glucose, Non-Invasive Glucose Monitoring
2) By Technology: Electrochemical Biosensors, Optical Biosensors
3) By End Users: Hospitals, Home Care, Diagnostic Centers and Clinics
Subsegments:
1) By Continuous Glucose Monitoring (CGM): Real-Time CGM Systems, Professional CGM Systems
2) By Self-Monitoring Blood Glucose (SMBG): Glucometers, Test Strips
3) By Non-Invasive Glucose Monitoring: Optical Glucose Sensors, Transdermal Sensors
Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Glucose Biosensors Market?
Major companies operating in the glucose biosensor market are focusing on developing innovative solutions such as next-generation continuous glucose monitoring (CGM) sensors that provide real-time, minute-by-minute glucose readings with optional alerts to improve diabetes management and patient safety. Next-generation continuous glucose monitoring (CGM) sensors are advanced devices that continuously measure glucose levels in the interstitial fluid every few minutes, providing real-time data, trend alerts, and optional alarms to help patients and clinicians manage diabetes more effectively. For instance, in August 2025, Abbott Laboratories, a US-based healthcare company, launched the next-generation FreeStyle Libre 2 Plus sensor, which delivers continuous glucose readings every minute directly to a compatible smartphone without manual scanning. The sensor provides automatic, real-time glucose monitoring, with optional customizable alerts for high or low glucose levels. Designed for ease of use, it is comfortable to wear for up to 15 days, suitable for children aged 2 and older, and can sync with apps to share data with caregivers and healthcare professionals.
Which Firms Hold A Significant Competitive Position In The Glucose Biosensors Market?
Major companies operating in the glucose biosensors market are Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Medtronic plc, Senseonics Holdings, GlySens Incorporated, LifeScan Inc., Ascensia Diabetes Care Holdings Inc., Nova Biomedical Corporation, AgaMatrix Inc., Trividia Health, Ypsomed AG, Universal Biosensors Inc., SD Biosensor Inc., Taidoc Technology Corporation, Nipro Corporation, i-SENS Inc., ACON Laboratories Inc., ARKRAY Inc., Menarini Diagnostics
Get Your In-Depth Glucose Biosensors Market Report Now:
Which Locations Are Showing Rapid Adoption And Strong Growth Indicators In The Glucose Biosensors Market?
North America was the largest region in the glucose biosensors market in 2025. The regions covered in the glucose biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment